Fosrenol and Phosphorus Balance - Lanthanum Carbonate

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Chronic Kidney FailureEnd-stage Renal DiseaseDisorders Associated With Peritoneal Dialysis
Interventions
DRUG

lanthanum carbonate

All patients will receive the following doses of lanthanum carbonate in random order for 10 -12 days each. O mg, 500 mg tid, 1000 mg tid, 1500 mg tid.

Trial Locations (1)

90509

Harbor-UCLA Medical Center, Torrance

All Listed Sponsors
lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT01581996 - Fosrenol and Phosphorus Balance - Lanthanum Carbonate | Biotech Hunter | Biotech Hunter